Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Down to the Short Strokes!!

<< Previous

Bullboard Posts

Next >>

Comment by McBullishon Nov 27, 2024 8:10pm

126 Views

Post# 36334804

RE:RE:Down to the Short Strokes!!

Agreed. I no way is not good news. So this is the second time they've failed to satisfy Pre-BTD requirements.

I will remain optimistic for the time being but if they miss their target for submittal next time due to anything I will have to re-evaluate my position.

Another concern is the administrative vs research expenses.. concerning.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features